{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:50:15Z","timestamp":1787637015284,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["CB22\/05\/00016"],"award-info":[{"award-number":["CB22\/05\/00016"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004755","name":"EMD Serono Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010553","name":"Consejer\u00eda de Sanidad de Castilla-La Mancha","doi-asserted-by":"publisher","award":["EXP_04"],"award-info":[{"award-number":["EXP_04"]}],"id":[{"id":"10.13039\/501100010553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["RD16\/0015\/0019"],"award-info":[{"award-number":["RD16\/0015\/0019"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["FI19\/00132"],"award-info":[{"award-number":["FI19\/00132"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI24\/00447"],"award-info":[{"award-number":["PI24\/00447"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI18\/00357"],"award-info":[{"award-number":["PI18\/00357"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI21\/00302"],"award-info":[{"award-number":["PI21\/00302"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["CB22\/05\/00016"],"award-info":[{"award-number":["CB22\/05\/00016"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.nbd.2025.106919","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T06:34:53Z","timestamp":1744871693000},"page":"106919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Circulating myeloid-derived suppressor cell load and disease severity are associated to an enhanced oligodendroglial production in a murine model of multiple sclerosis"],"prefix":"10.1016","volume":"210","author":[{"given":"Mari Paz","family":"Serrano-Regal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Camacho-Toledano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Alonso-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Cristina","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Mach\u00edn-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Lebr\u00f3n-Gal\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9nnifer","family":"Garc\u00eda-Arocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Calahorra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Nieto-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2025.106919_bb0005","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nn738","article-title":"TNF\u03b1 promotes proliferation of oligodendrocyte progenitors and remyelination","volume":"4","author":"Arnett","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2025.106919_bb0010","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ana.24620","article-title":"Dynamic imaging of individual remyelination profiles in multiple sclerosis","volume":"79","author":"Bodini","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.106919_bb0015","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00401-013-1112-y","article-title":"Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models","volume":"125","author":"Boyd","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2025.106919_bb0020","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/glia.22616","article-title":"Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination","volume":"62","author":"Brambilla","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2025.106919_bb0025","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3390\/jcm9061681","article-title":"Functional heterogeneity of mouse and human brain OPCs: relevance for preclinical studies in multiple sclerosis","volume":"9","author":"Bribi\u00e1n","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.nbd.2025.106919_bb0030","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2025.106919_bb0035","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S1474-4422(19)30137-1","article-title":"Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial","volume":"18","author":"Cadavid","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2025.106919_bb0040","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12974-022-02635-3","article-title":"Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis","volume":"19","author":"Camacho-Toledano","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2025.106919_bb0045","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00401-015-1388-1","article-title":"TREM2 regulates microglial cell activation in response to demyelination in vivo","volume":"129","author":"Cantoni","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2025.106919_bb0050","doi-asserted-by":"crossref","first-page":"14899","DOI":"10.1523\/JNEUROSCI.1158-11.2011","article-title":"FGF-2 and Anosmin-1 are selectively expressed in different types of multiple sclerosis lesions","volume":"31","author":"Clemente","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106919_bb0055","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1093\/brain\/awac207","article-title":"Validating visual evoked potentials as a preclinical, quantitative biomarker for remyelination efficacy","volume":"145","author":"Cordano","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.106919_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1132170","article-title":"Are highly active and aggressive multiple sclerosis the same entity?","volume":"14","author":"Correale","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2025.106919_bb0065","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ajpath.2013.04.016","article-title":"Oligodendrocyte progenitor cell susceptibility to injury in multiple sclerosis","volume":"183","author":"Cui","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2025.106919_bb0070","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191390","article-title":"Pro-inflammatory activation following demyelination is required for myelin clearance and oligodendrogenesis","volume":"217","author":"Cunha","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2025.106919_bb0075","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.nbd.2025.106919_bb0080","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12647","article-title":"A regenerative approach to the treatment of multiple sclerosis","volume":"502","author":"Deshmukh","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2025.106919_bb0085","doi-asserted-by":"crossref","DOI":"10.1177\/1756286419833574","article-title":"The monoclonal antibody GNbAC1: targeting human endogenous retroviruses in multiple sclerosis","volume":"12","author":"Diebold","year":"2019","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.nbd.2025.106919_bb0090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.nbd.2025.106919_bb0095","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrn.2017.136","article-title":"Regenerating CNS myelin \u2014 from mechanisms to experimental medicines","volume":"18","author":"Franklin","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2025.106919_bb0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ana.25128","article-title":"Myeloid cell plasticity in the evolution of central nervous system autoimmunity","volume":"83","author":"Giles","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.106919_bb0105","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00401-020-02189-9","article-title":"Lesion stage-dependent causes for impaired remyelination in MS","volume":"140","author":"He\u00df","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2025.106919_bb0110","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00401-017-1745-3","article-title":"Nogo-a antibodies enhance axonal repair and remyelination in neuro-inflammatory and demyelinating pathology","volume":"134","author":"Ineichen","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2025.106919_bb0115","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41586-019-0903-2","article-title":"Altered human oligodendrocyte heterogeneity in multiple sclerosis","volume":"566","author":"J\u00e4kel","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2025.106919_bb0120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12974-024-03019-5","article-title":"Microglia-derived exosomes modulate myelin regeneration via miR-615-5p\/MYRF axis","volume":"21","author":"Ji","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2025.106919_bb0125","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00401-023-02645-2","article-title":"Microglia activation in periplaque white matter in multiple sclerosis depends on age and lesion type, but does not correlate with oligodendroglial loss","volume":"146","author":"Kessler","year":"2023","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2025.106919_bb0130","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S1474-4422(10)70064-8","article-title":"The changing demographic pattern of multiple sclerosis epidemiology","volume":"9","author":"Koch-Henriksen","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2025.106919_bb0135","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9440(10)64537-3","article-title":"Multiple sclerosis and chronic autoimmune encephalomyelitis","volume":"157","author":"Kornek","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2025.106919_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005757","article-title":"Dynamics and heterogeneity of brain damage in multiple sclerosis","volume":"13","author":"Kotelnikova","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.nbd.2025.106919_bb0145","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1523\/JNEUROSCI.2615-05.2006","article-title":"Myelin impairs CNS Remyelination by inhibiting oligodendrocyte precursor cell differentiation","volume":"26","author":"Kotter","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106919_bb0150","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/brain\/awn096","article-title":"Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis","volume":"131","author":"Kuhlmann","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.106919_bb0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00401-016-1653-y","article-title":"An updated histological classification system for multiple sclerosis lesions","volume":"133","author":"Kuhlmann","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2025.106919_bb0160","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/s41593-018-0212-3","article-title":"Mononuclear phagocytes locally specify and adapt their phenotype in a multiple sclerosis model","volume":"21","author":"Locatelli","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2025.106919_bb0165","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S1474-4422(20)30140-X","article-title":"Remyelination in multiple sclerosis: from basic science to clinical translation","volume":"19","author":"Lubetzki","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2025.106919_bb0170","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00401-018-1818-y","article-title":"Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis","volume":"135","author":"Luchetti","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2025.106919_bb0175","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41593-019-0581-2","article-title":"Functionally distinct subgroups of oligodendrocyte precursor cells integrate neural activity and execute myelin formation","volume":"23","author":"Marisca","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2025.106919_bb0180","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1523\/JNEUROSCI.21-18-07046.2001","article-title":"Interleukin-1\u03b2 promotes repair of the CNS","volume":"21","author":"Mason","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106919_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104868","article-title":"Regulatory T cells promote remyelination in the murine experimental autoimmune encephalomyelitis model of multiple sclerosis following human neural stem cell transplant","volume":"140","author":"McIntyre","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106919_bb0190","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18246","article-title":"Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery","volume":"5","author":"Mei","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.nbd.2025.106919_bb0195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2019.02.014","article-title":"The presence and suppressive activity of myeloid-derived suppressor cells are potentiated after interferon-\u03b2 treatment in a murine model of multiple sclerosis","volume":"127","author":"Melero-Jerez","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106919_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104869","article-title":"The proportion of myeloid-derived suppressor cells in the spleen is related to the severity of the clinical course and tissue damage extent in a murine model of multiple sclerosis","volume":"140","author":"Melero-Jerez","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106919_bb0205","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/glia.23936","article-title":"Myeloid-derived suppressor cells support remyelination in a murine model of multiple sclerosis by promoting oligodendrocyte precursor cell survival, proliferation, and differentiation","volume":"69","author":"Melero-Jerez","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2025.106919_bb0210","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.neuron.2023.03.031","article-title":"Remyelination by surviving oligodendrocytes is inefficient in the inflamed mammalian cortex","volume":"111","author":"Mezydlo","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.106919_bb0215","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nn.3469","article-title":"M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination","volume":"16","author":"Miron","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2025.106919_bb0220","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1750-3639.2011.00495.x","article-title":"Myeloid-derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis","volume":"21","author":"Molin\u00e9-Vel\u00e1zquez","year":"2011","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2025.106919_bb0225","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.nbd.2014.03.017","article-title":"The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability","volume":"67","author":"Molin\u00e9-Vel\u00e1zquez","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106919_bb0230","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1523\/JNEUROSCI.0849-14.2015","article-title":"Demyelination causes adult CNS progenitors to revert to an immature state and express immune cues that support their migration","volume":"35","author":"Moyon","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106919_bb0235","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41593-021-01009-x","article-title":"New oligodendrocytes exhibit more abundant and accurate myelin regeneration than those that survive demyelination","volume":"25","author":"Neely","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2025.106919_bb0240","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00401-023-02593-x","article-title":"Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis","volume":"146","author":"Ortega","year":"2023","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2025.106919_bb0245","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00415-016-8341-7","article-title":"Lesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: a randomised, single-blind, phase II study","volume":"264","author":"Schwartzbach","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2025.106919_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.721376","article-title":"Shaping of regional differences in oligodendrocyte dynamics by regional heterogeneity of the Pericellular microenvironment","volume":"15","author":"Sherafat","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2025.106919_bb0255","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ana.24201","article-title":"Early netrin-1 expression impairs central nervous system remyelination","volume":"76","author":"Tepav\u010devi\u0107","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.106919_bb0260","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708743","article-title":"P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis","volume":"10","author":"Zabala","year":"2018","journal-title":"EMBO Mol. Med."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125001354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125001354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:56:35Z","timestamp":1778576195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125001354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":52,"alternative-id":["S0969996125001354"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.106919","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.07.18.604171","asserted-by":"object"}]},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating myeloid-derived suppressor cell load and disease severity are associated to an enhanced oligodendroglial production in a murine model of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.106919","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106919"}}